Wildcat Capital Management, LLC - Q1 2023 holdings

$269 Million is the total value of Wildcat Capital Management, LLC's 23 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 46.4% .

 Value Shares↓ Weighting
RLX SellRLX TECHNOLOGY INCsponsored ads$52,333,966
-26.3%
18,046,195
-41.6%
19.45%
-28.3%
GSHD BuyGOOSEHEAD INS INC$26,935,618
+119.9%
516,008
+44.7%
10.01%
+114.1%
FB SellMETA PLATFORMS INCcl a$26,766,115
+69.1%
126,291
-4.0%
9.95%
+64.6%
GLBE SellGLOBAL E ONLINE LTD$23,736,654
+49.9%
736,477
-4.0%
8.82%
+45.9%
TDG SellTRANSDIGM GROUP INC$22,371,679
+0.5%
30,353
-14.2%
8.31%
-2.2%
GWRE BuyGUIDEWIRE SOFTWARE INC$18,663,011
+107.3%
227,459
+58.0%
6.94%
+101.7%
Z SellZILLOW GROUP INCcl c cap stk$17,417,209
+32.5%
391,662
-4.0%
6.47%
+29.0%
FYBR SellFRONTIER COMMUNICATIONS PARE$15,859,396
-14.2%
696,504
-4.0%
5.89%
-16.5%
SKLZ SellSKILLZ INC$11,624,933
+6.1%
19,596,988
-9.4%
4.32%
+3.3%
MSFT NewMICROSOFT CORP$11,532,00040,000
+100.0%
4.28%
ALLO SellALLOGENE THERAPEUTICS INC$9,488,688
-29.1%
1,920,787
-9.8%
3.53%
-31.0%
MCO SellMOODYS CORP$9,400,934
+5.4%
30,720
-4.0%
3.49%
+2.6%
CNSL BuyCONSOLIDATED COMM HLDGS INC$6,732,384
+11.3%
2,609,451
+54.4%
2.50%
+8.4%
SellEUROPEAN WAX CTR INC$4,594,048
-44.2%
241,792
-63.4%
1.71%
-45.7%
URGN SellUROGEN PHARMA LTD$4,579,399
-3.2%
495,606
-7.0%
1.70%
-5.7%
KRON SellKRONOS BIO INC$1,895,020
-18.7%
1,297,959
-9.8%
0.70%
-20.9%
SNOW SellSNOWFLAKE INCcl a$1,678,058
-48.3%
10,876
-51.9%
0.62%
-49.6%
PCOR NewPROCORE TECHNOLOGIES INC$1,069,15717,071
+100.0%
0.40%
SellAKILI INC$872,472
+28.9%
545,295
-9.8%
0.32%
+25.6%
INVZ NewINNOVIZ TECHNOLOGIES LTD$810,618231,605
+100.0%
0.30%
MELI NewMERCADOLIBRE INC$413,871314
+100.0%
0.15%
SellGITLAB INC$316,805
-70.0%
9,239
-60.2%
0.12%
-70.7%
 NERDY INC*w exp 08/16/202$22,9080.0%99,6000.0%0.01%0.0%
ExitROBINHOOD MKTS INC$0-13,876
-100.0%
-0.04%
ExitVACASA INC$0-100,000
-100.0%
-0.05%
ExitTOAST INCcl a$0-10,887
-100.0%
-0.08%
OYST ExitOYSTER PT PHARMA INC$0-36,847
-100.0%
-0.16%
CXM ExitSPRINKLR INCcl a$0-59,945
-100.0%
-0.19%
DDOG ExitDATADOG INC$0-9,731
-100.0%
-0.27%
DASH ExitDOORDASH INCcl a$0-20,460
-100.0%
-0.38%
ExitNERDY INC$0-547,800
-100.0%
-0.47%
CPNG ExitCOUPANG INCcl a$0-1,371,669
-100.0%
-7.70%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-05-12
  • View 13F-HR/A filed 2023-08-10
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
COSTAR GROUP INC32Q3 202248.3%
UROGEN PHARMA LTD26Q3 202317.3%
META PLATFORMS INC26Q3 20239.9%
ALLOGENE THERAPEUTICS INC18Q3 202322.4%
GOOSEHEAD INSURANCE INC -A18Q3 202315.4%
SABINE RTY TRUST18Q3 202111.3%
LPL FINL HLDGS INC18Q1 201912.7%
PLAYA HOTELS & RESORTS NV18Q3 20213.4%
NANTKWEST INC17Q3 201922.0%
SORRENTO THERAPEUTICS INC17Q2 20197.0%

View Wildcat Capital Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Wildcat Capital Management, LLC Q1 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Skillz Inc.January 05, 202319,596,9885.6%
UroGen Pharma Ltd.February 14, 2022533,1392.4%
Skillz Inc.March 08, 202121,832,0227.5%
NantKwest, Inc.February 13, 2018808,9741.0%
Sorrento Therapeutics, Inc.February 13, 20181,738,2322.2%

View Wildcat Capital Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
32024-04-08
SC 13G2024-04-08
13F-HR2024-02-13
13F-HR2023-11-09
PX14A6G2023-11-03
13F-HR2023-08-11
13F-HR/A2023-08-10
13F-HR2023-05-12
13F-HR2023-02-07
SC 13D/A2023-01-05

View Wildcat Capital Management, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been amended

Export Wildcat Capital Management, LLC's holdings